Position in VKTX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$7,199,022
+$1,048,051 QoQ
Shares Held
184,543
-2.4% QoQ
Ownership
0.158%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#61
of 432 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in VKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Cetera Investment Advisers holds $187,106,390 across 112 Biotechnology names. VKTX ranks #7 (3.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
78,107 | $38,798,090 | |
| 2 | IBRX |
ImmunityBio, Inc.
|
1,140,476 | $9,984,867 | |
| 3 | EXEL |
Exelixis, Inc.
|
169,657 | $9,231,037 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
14,664 | $9,143,590 | |
| 5 | OCUL |
Ocular Therapeutix, Inc
|
785,732 | $7,715,888 | |
| 6 | ARGX |
Argenx SE
|
7,844 | $7,277,427 | |
| 7 | VKTX |
Viking Therapeutics, Inc.
This page
|
184,543 | $7,199,022 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
23,196 | $6,982,691 |
All Filings in VKTX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,199,022 | 184,543 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $6,150,971 | 189,028 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $6,671,394 | 189,636 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,953,017 | 188,471 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $4,177,407 | 157,638 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $3,486,028 | 144,349 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $3,467,923 | 86,181 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $5,099,430 | 80,547 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $2,613,976 | 49,311 | Shares | Sole | 2024-08-22 | |
| 2024-03-31 | $1,889,362 | 23,041 | Shares | Sole | 2024-05-24 | |
| No filing history on record for this holder in this stock. | ||||||